Residual mass and negative gallium scintigraphy in treated lymphoma.

Ora Israel(Technion – Israel Institute of Technology), Eliezer Robinson, Jacqueline Jerushalmi, Dov Front(Rambam Health Care Campus), Einat Even‐Sapir(Tel Aviv Sourasky Medical Center), Ron Epelbaum(University of Bern), U Kleinhaus, Simona Ben‐Haim(Investigators Research Group (United States))
PubMed
March 1, 1990
Cited by 36

Related Papers

Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications
|Current Medicinal Chemistry|2009|480
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers
|British Journal of Cancer|2014|444
<sup>18</sup>F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients
|Journal of Nuclear Medicine|2009|381
Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer
|Nutrition and Cancer|2010|279
Endocrinology: Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy
|Human Reproduction|1996|266